"Clinicians should be vigilant in monitoring signs and symptoms of cardiovascular diseases, particularly among those receiving higher doses," Zheng Chang, PhD
"The potential risk for CVD associated with long-term ADHD medication use remains unclear. Most 'longitudinal' studies that have looked at the association have an average follow-up time of no more than 2 years, the authors note."
"Treatment decisions, as always, should be based on careful weighing of potential benefits and risks at individual patient level, rather than simple one-size-fits-all recommendations," Chang added.
[
Collection
]
[
|
...
]